tradingkey.logo
๎™๊ฒ€์ƒ‰
์‹œ์žฅ
๊ด€์‹ฌ ๋ชฉ๋ก
๋‰ด์Šค
๋ถ„์„
๋„๊ตฌ
์ข…๋ชฉ ์Šคํฌ๋ฆฌ๋„ˆ
๎™ผ
๎˜
English
็นไฝ“ไธญๆ–‡
เน„เธ—เธข
Tiแบฟng viแป‡t
็ฎ€ไฝ“ไธญๆ–‡
Espaรฑol
Portuguรชs
Deutsch
ํ•œ๊ตญ์–ด
๎˜ณ
ๆ—ฅๆœฌ่ชž
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™
๎˜

Prelude Therapeutics Inc

PRLD
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
3.990USD
-0.320-7.42%
์ข…๊ฐ€ย 09-24 16:00๏ผˆET๏ผ‰
317.80M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

Prelude Therapeutics Inc

3.990
-0.320-7.42%
๊ฐœ์š”
๋‰ด์Šค & ๋ถ„์„
๊ธˆ์œต
์ฃผ์‹ ์ ์ˆ˜
๊ธฐ์ˆ 
์˜ˆ์ƒ
์†Œ์œ ๊ถŒ
๋ฐฐ๋‹น๊ธˆ
ํ”„๋กœํ•„
ํ† ๋ก 
์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

๊ฐœ์š”

๋‰ด์Šค & ๋ถ„์„

๊ธˆ์œต

์ฃผ์‹ ์ ์ˆ˜

๊ธฐ์ˆ 

์˜ˆ์ƒ

์†Œ์œ ๊ถŒ

๋ฐฐ๋‹น๊ธˆ

ํ”„๋กœํ•„

ํ† ๋ก 

์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

PRLD ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Prelude Therapeutics Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋Š ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ

์‹œ๊ฐ€์ด์•ก
317.80M
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
-4.01
์ฃผ๋‹น์ˆœ์ด์ต
-1.00
์ˆ˜์ต
12.14M
์ˆœ์ด์ต
-127.17M
ROE
-95.25%
ROA
-59.64%

Prelude Therapeutics Inc ์‹ค์  ๋ฐœํ‘œ์ผ๎˜

์ตœ์‹  ์ถœ์‹œ
Aug 11, 2026
EPS / ์˜ˆ์ƒ
-0.14/-0.20
์ˆ˜์ต / ์˜ˆ์ƒ
5.70M/0.00

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
์žฌ๋ฌด ์ง€ํ‘œ
EPS
65.57%-0.14
70.20%-0.13
45.48%-0.21
39.10%-0.26
10.37%-0.41
-1.74%-0.42
20.32%-0.38
5.99%-0.43
15.26%-0.46
28.53%-0.42
20.86%-0.48
---0.45
---0.54
---0.58
---0.60
---1.84
----
----
----
----
์ˆ˜์ต
--5.70M
--4.58M
41.00%5.64M
116.67%6.50M
----
----
--4.00M
--3.00M
----
----
----
----
----
----
----
----
----
----
----
----
์ˆœ์ด์ต
55.43%-13.92M
67.63%-10.38M
42.72%-16.46M
38.88%-19.73M
10.10%-31.23M
-2.08%-32.09M
13.13%-28.73M
-5.43%-32.27M
-14.16%-34.74M
-13.40%-31.43M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
12.79%-28.64M
2.38%-29.96M
-1.89%-27.37M
-38.33%-29.46M
-70.61%-32.84M
-83.10%-30.69M
์ˆœ์ด์ต๋ฅ 
---244.06%
---226.75%
59.38%-291.79%
71.79%-303.46%
----
----
---718.27%
---1075.70%
----
----
----
----
----
----
----
----
----
----
----
----
์ด ์ด์ต๋ฅ 
--100.00%
--100.00%
0.00%100.00%
0.00%100.00%
----
----
--100.00%
--100.00%
----
----
----
----
----
----
----
----
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
----
----
-100.00%0.00%
-100.00%0.00%
-100.00%0.00%
--0.04%
--0.12%
--0.18%
--0.23%
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
์†์ต๊ณ„์‚ฐ์„œ๎˜
์ˆ˜์ต
--5.70M
--4.58M
41.00%5.64M
116.67%6.50M
----
----
--4.00M
--3.00M
----
----
----
----
----
----
----
----
----
----
----
----
์˜์—… ์ด์ต
52.00%-15.45M
59.03%-14.18M
48.72%-17.35M
40.60%-20.42M
13.37%-32.19M
-0.77%-34.61M
9.49%-33.83M
-2.97%-34.38M
-14.71%-37.16M
-17.96%-34.34M
-11.96%-37.38M
-9.80%-33.38M
-9.97%-32.40M
3.87%-29.11M
-1.14%-33.38M
1.39%-30.41M
-5.51%-29.46M
-37.88%-30.29M
-69.75%-33.01M
-69.95%-30.84M
์ˆœ์ด์ต
55.43%-13.92M
67.63%-10.38M
42.72%-16.46M
38.88%-19.73M
10.10%-31.23M
-2.08%-32.09M
13.13%-28.73M
-5.43%-32.27M
-14.16%-34.74M
-13.40%-31.43M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
12.79%-28.64M
2.38%-29.96M
-1.89%-27.37M
-38.33%-29.46M
-70.61%-32.84M
-83.10%-30.69M
์žฌ๋ฌด์ƒํƒœํ‘œ๎˜
์œ ๋™์ž์‚ฐ
101.49%154.90M
-17.39%84.59M
-22.23%105.69M
-62.70%58.33M
-57.93%76.88M
-50.14%102.40M
-42.32%135.90M
-33.43%156.39M
-29.78%182.71M
17.18%205.37M
15.27%235.59M
3.54%234.92M
4.66%260.21M
-35.08%175.26M
-30.75%204.38M
-30.38%226.89M
-27.85%248.62M
-26.04%269.97M
33.65%295.12M
36.90%325.90M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
81.95%38.04M
110.85%41.72M
106.68%52.99M
-18.15%18.19M
-10.40%20.91M
12.15%19.79M
17.46%25.64M
31.56%22.22M
53.62%23.34M
-10.27%17.64M
0.59%21.83M
-21.65%16.89M
-3.93%15.19M
22.36%19.66M
13.03%21.70M
9.65%21.56M
7.73%15.81M
29.34%16.07M
68.80%19.20M
73.11%19.66M
์ด ์ž์‚ฐ
64.78%189.36M
-15.30%119.64M
-19.49%141.31M
-51.95%94.75M
-48.76%114.92M
-42.83%141.26M
-36.79%175.51M
-23.71%197.22M
-20.07%224.29M
24.60%247.11M
25.93%277.67M
6.68%258.51M
8.32%280.61M
-29.34%198.32M
-27.73%220.50M
-26.84%242.33M
-25.90%259.06M
-24.11%280.67M
36.45%305.10M
38.19%331.22M
๋ถ€์ฑ„ ์ด๊ณ„
42.35%55.63M
56.13%59.46M
64.97%72.68M
-11.20%36.22M
-6.99%39.08M
4.70%38.08M
8.58%44.06M
101.39%40.79M
126.48%42.02M
57.98%36.37M
61.89%40.58M
-18.72%20.25M
1.87%18.55M
22.08%23.02M
30.53%25.06M
24.76%24.92M
19.65%18.21M
42.18%18.86M
68.33%19.20M
75.62%19.98M
์ž๋ณธ ์ด๊ณ„
76.34%133.73M
-41.67%60.18M
-47.79%68.64M
-62.58%58.53M
-58.39%75.84M
-51.04%103.18M
-44.55%131.46M
-34.34%156.43M
-30.44%182.28M
20.22%210.73M
21.31%237.09M
9.59%238.26M
8.81%262.06M
-33.04%175.30M
-31.64%195.44M
-30.15%217.41M
-27.97%240.84M
-26.57%261.81M
34.74%285.90M
36.33%311.24M
ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๎˜
์ˆœ์˜์—…์ด์ต
40.27%-15.57M
36.65%-21.68M
211.45%23.12M
29.97%-19.11M
-13.09%-26.07M
-7.68%-34.23M
12.02%-20.74M
-6.28%-27.30M
16.67%-23.06M
-5.50%-31.79M
-2.84%-23.58M
-25.66%-25.68M
-49.82%-27.67M
-37.63%-30.13M
10.80%-22.93M
6.13%-20.44M
7.25%-18.47M
-35.63%-21.89M
-73.11%-25.70M
-74.09%-21.77M
์ˆœํˆฌ์ž
-668.55%-65.50M
-86.33%8.50M
-372.80%-60.34M
273.53%40.09M
-55.89%11.52M
99.18%62.19M
185.91%22.12M
-28.66%10.73M
134.63%26.12M
73.46%31.22M
470.92%7.74M
-30.37%15.04M
-539.01%-75.43M
-56.68%18.00M
175.11%1.35M
108.29%21.61M
4609.45%17.18M
4313.79%41.55M
-448.33%-1.80M
-153212.94%-260.63M
์ˆœ์žฌ๋ฌดํ™œ๋™
231845.95%85.82M
-96.25%-314.00K
73464.71%24.94M
96.18%-5.00K
-37.29%37.00K
-1042.86%-160.00K
-100.13%-34.00K
-248.86%-131.00K
-99.95%59.00K
94.80%-14.00K
16181.94%25.24M
-40.54%88.00K
30913.65%111.34M
-275.82%-269.00K
-92.07%155.00K
-79.18%148.00K
-14.93%359.00K
-99.91%153.00K
249.50%1.95M
-99.67%711.00K

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Prelude Therapeutics Inc์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Prelude Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 12.14M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 7.00M์ž…๋‹ˆ๋‹ค.

Prelude Therapeutics Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Prelude Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 105.69M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -22.23์ž…๋‹ˆ๋‹ค.

Prelude Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Prelude Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Prelude Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ 141.31M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -19.49์ž…๋‹ˆ๋‹ค.

Prelude Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Prelude Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Prelude Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” 72.68M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 64.97์ž…๋‹ˆ๋‹ค.

Prelude Therapeutics Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Prelude Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Prelude Therapeutics Inc์˜ ์ด์ž๋ณธ์€ 68.64M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -47.79์ž…๋‹ˆ๋‹ค.

Prelude Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Prelude Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Prelude Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -104.57M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 25.16์ž…๋‹ˆ๋‹ค.

Prelude Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Prelude Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Prelude Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” 53.46M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -40.73์ž…๋‹ˆ๋‹ค.

Prelude Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Prelude Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Prelude Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 24.82M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 20780.00์ž…๋‹ˆ๋‹ค.

Prelude Therapeutics Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Prelude Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -1.29์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 22.93์ž…๋‹ˆ๋‹ค.

Prelude Therapeutics Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Prelude Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -99.50M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 21.76์ž…๋‹ˆ๋‹ค.

Prelude Therapeutics Inc์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Prelude Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ -819.59์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 54.89์ž…๋‹ˆ๋‹ค.

Prelude Therapeutics Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Prelude Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -99.45์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -44.10์ž…๋‹ˆ๋‹ค.

Prelude Therapeutics Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Prelude Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -62.81์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -11.91์ž…๋‹ˆ๋‹ค.

Prelude Therapeutics Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Prelude Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -104.57M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 25.16์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
์ด์šฉ ์•ฝ๊ด€
๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ
์ฟ ํ‚ค ์ •์ฑ